Margaret Keegan joins RQM+ as new CEO
pharmafile | March 29, 2022 | Appointment | |
RQM+, a world leading provider of regulatory, clinical and quality solutions to the MedTech industry, announced the appointment of life science executive Magaret Keegan as their new CEO.
Keegan brings three decades of experience with executive roles at the largest life sciences service providers in the world, including PPD, IQVIA, and most recently PRA Health Sciences, where she was chief operating officer.
“It’s an incredibly exciting time to lead RQM+,” said Keegan. “By using innovative models that integrate best practices from across the life sciences spectrum, we have a tremendous opportunity to help our MedTech customers bring their products to market faster, and keep them there. I look forward to applying my clinical and pharma experience to help RQM+ create solutions that leverage technology, expert knowledge and data insights. I am committed to continuing to make RQM+ the partner of choice for our customers and the destination of choice for world-leading MedTech talent. With our unrivaled collective knowledge and deep expertise, we help manufacturers overcome their unique challenges to ensure that patients continue to receive high-quality, life-improving treatments.”